The current financial score of Mesa Laboratories Inc is 7.47. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 62.34M, representing a year-over-year increase of 2.63%, while its net profit experienced a year-over-year increase of 75.32%.
The current valuation score of Mesa Laboratories Inc is 9.06. Its current P/E ratio is 211.51, which is 398.67% below the recent high of 1054.75 and 515.16% above the recent low of -878.12.
The current earnings forecast score of Mesa Laboratories Inc is 8.00. The average price target is 125.00, with a high of 125.00 and a low of 125.00.
The current price momentum score of Mesa Laboratories Inc is 4.26. Currently, the stock price is trading between the resistance level at 148.66 and the support level at 123.69, making it suitable for range-bound swing trading.
The current institutional shareholding score of Mesa Laboratories Inc is 10.00. The latest institutional shareholding proportion is 100.49%, representing a quarter-over-quarter increase of 17.49%.
The current risk assessment score of Mesa Laboratories Inc is 6.59. The company's beta value is 0.94. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.